“We intend to concern outcomes of the first evaluation inside 48 hours,” it stated.
London: Pharmaceutical firm AstraZeneca stated Tuesday it’s going to launch additional information “inside 48 hours” on trials in america of its Covid-19 vaccine, after well being officers raised considerations about preliminary info disclosed.
“We have now reviewed the preliminary evaluation of the first evaluation and the outcomes have been according to the interim evaluation,” the corporate stated in a press release.
“We intend to concern outcomes of the first evaluation inside 48 hours.”
(Apart from the headline, this story has not been edited by NDTV workers and is printed from a syndicated feed.)
